FTH

7.9108.98%
RH

Robert Holmen

Independent Director

Mr. Robert Holmen, also known as Bob, J.D. serves as Finance & Legal Administration at Miramar Digital Ventures and previously served as Managing Director. He serves as a Director of Alvaxa Biosciences since January 2017. Mr. Holmen was a General Counsel at Aequitas Capital Management, Inc. He also serves as Adjunct Professor, teaching graduate courses on Venture Capital. He teaches “Venture Capital Law” at the UC Irvine School of Law. Mr. Holmen has lectured courses in venture capital law, venture initiation, as well as entrepreneurship at University of California Irvine. He was Co-Founder and Managing Director of Miramar Venture Partner, L.P. Mr. Holmen was responsible for investments in advanced technology projects. His previous experience also includes serving as General Counsel for public and private companies in healthcare and information technology. From 2012-2014, he taught Investing in New Ventures as an Adjunct Professor in the MBA Program at USC's Marshall School of Business. He has served in diverse roles, from software engineer at Hughes Aircraft to senior executive roles at technology and life sciences companies to venture investor. Prior to the firm, Mr. Holmen served as a Vice President, General Counsel and Secretary at First Consulting Group, Inc. He also served an integral role in the creation and operations of First Ventures. He was also an Associate Attorney at Latham & Watkins LLP and Morrison & Foerster, LLP, where his key responsibilities included finance and mergers and acquisition transactions for technology and life science companies. He served as Acting Chief Financial Officer, Secretary, General Counsel and Vice President of SiliconSystems Inc. From 1997 to 1999, he served as a General Counsel and Secretary and later as a Vice President and acting Chief Financial Officer of CoCensys, Inc. He was Principal of Holmen Ventures, since 2013. Mr. Holmen was responsible for the finance, intellectual property and legal departments. From 1994 to 1997, he served as a Corporate Counsel and Member of Senior Management at National Education Corporation. He began his career as a hardware and software Engineer at Hughes Aircraft, as a Member of the Technical Staff, designing and programming application software and integrating hardware and software for defense related projects. He serves as a an Independent Director at Faeth Therapeutics, Inc. (formerly known as Sensei Biotherapeutics, Inc.) since January 2017 and served as its Independent Chairman until 2026. He serves on the Board of Directors of the San Diego Venture Group. Mr. Holmen also serves on the Boards of many Miramar Digital Ventures portfolio companies including Brickfish, Cirro, Inc., Independa, Inc., Matrix Sensors, Inc. and Predixion Software, Inc. He served as a Board Observer at Solarflare Communications, Inc. He served as a Director at Get Lower Inc.; FastSoft, Inc. Mr. Holmen also served on the Board of SiliconSystems Inc. until March 2009 and CaseRev, Inc. He serves on the Board of Life College. Mr. Holmen has experience in building technology companies in the healthcare and information technology markets and advising technology, healthcare and financial services companies. He has great experience operating and advising public and venture-backed companies. Mr. Holmen received a J.D. from University of California, Berkeley School of Law in 1989 and received a B.S. in Electrical Engineering from Stanford University in 1985, serving as an officer of the national engineering honor society at Stanford.

Positions